Efficacy of Noble Metal–alloy Endotracheal Tubes in Ventilator- associated Pneumonia Prevention: a Randomized Clinical Trial

Efficacy of Noble Metal–alloy Endotracheal Tubes in Ventilator- associated Pneumonia Prevention: a Randomized Clinical Trial

Background: Endotracheal tube (ETT) is an important risk factor for the development of Ventilator-associated pneumonia (VAP), as it acts as a reservoir for infectious microorganisms and bypasses the host’s defenses. One of the preventive measures for VAP is endotracheal tube composition. It has been reported that biofilm formation is reduced by using ETTs coated with pure silver or silver compounds. However, noble metal-alloy ETTs have not been adequately studied. Aims: To evaluate the efficacy of noble metal alloy ETT (coated Bactiguard Infection Protection ETTs) in preventing VAP compared to standard non-coated ETTs in patients requiring ≥ 48 hours of mechanical ventilation and presenting for coma due to drug intoxication. Study Design: Randomized controlled study. Methods: Participants were randomized using sealed envelopes with a concealed 1:1 allocation to either the intervention group or the control group. The intervention group used a noble metal–alloy ETT, while the control group received standard ETT. The primary outcomes were the incidence of VAP (per ventilated patients) and the duration of mechanical ventilation. Results: Initially, a total of 188 patients were assessed for eligibility, and the final allocation group consisted of 180 patients, who were subsequently randomized into the intervention group (n = 97) and control group (n = 83). The incidence of VAP in the intervention and control groups was 27.83% and 43.16% (P = 0.03), and the VAP ratio per 1000 ventilation days was 51.26/1000 and 83.38/1000 (P = 0.01), respectively. The mean durations of mechanical ventilation were 3.2 ± 0.78 in the intervention group and 5.03 ± 1.88 in the control group (P = 0.22). There was no statistically significant difference between groups in terms of mortality and duration of hospital stay. Conclusion: Noble metal-alloy ETT reduces the incidence of VAP, ventilation days, and ICU stay for patients in mechanical ventilation.

___

  • 1. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clinical Microbiol Rev. 2006;19:637-657. [CrossRef]
  • 2. Buczko W. Ventilator-associated pneumonia among elderly Medicare beneficiaries in long-term care hospitals. Health Care Financ Rev. 2009;31:1-10. [CrossRef]
  • 3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903. [CrossRef]
  • 4. Fernandez JF, Levine SM, Restrepo MI. Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia. Chest. 2012;142:231-238. [CrossRef]
  • 5. Koerner RJ. Contribution of endotracheal tubes to the pathogenesis of ventilator- associated pneumonia. J Hosp Infect. 1997;35:83-89. [CrossRef]
  • 6. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300:805-813. [CrossRef]
  • 7. Rello J, Kollef M, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med. 2006;34:2766-2772. [CrossRef]
  • 8. Berra L, Kolobow T, Laquerriere P, et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 2008;34:1030-1037. [CrossRef]
  • 9. Björling G, Johansson D, Bergström L, et al. Tolerability and performance of BIP endotracheal tubes with noble metal alloy coating--a randomized clinical evaluation study. BMC Anesthesiol. 2015;15:174. [CrossRef]
  • 10. Lorente L, Lecuona M, Jim ́enez A, Mora ML, Sierra A. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med. 2007;176:1079-1083. [CrossRef]
  • 11. Camargo LFA, De Marco FV, Barbas CSV, et al. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care. 2004;8:R422-430. [CrossRef]
  • 12. Mietto C, Pinciroli R, Patel N, Berra L. Ventilator associated pneumonia: Evolving definitions and preventive strategies. Respir Care. 2013;58:990-1007. [CrossRef]
  • 13. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332. [CrossRef]
  • 14. Rouzé A, Martin-Loeches I, Nseir S. Improved endotracheal tubes for prevention of ventilator-associated pneumonia: Better than silver and gold? Respir Care. 2019;64:108-109. [CrossRef]
  • 15. Bologna RA, Tu LM, Polansky M, Fraimow HD, Gordon DA, Whitmore KE. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology. 1999;54:982-987. [CrossRef]
  • 16. Berra L, De Marchi L, Yu ZX, Laquerriere P, Baccarelli A, Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology. 2004;100:1446-1456. [CrossRef]
  • 17. Berra L, Kolobow T, Laquerriere P, et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 2008;34:1030-1037. [CrossRef]
  • 18. Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth. 2010;54:535-540. [CrossRef]
  • 19. Kollef MH, Afessa B, Anzueto A, et al. NASCENT Investigation Group Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300:805-813. [CrossRef]
  • 20. Becheanu CA, Tincu IF, Smadeanu RE, et al. Benefits of oligofructose and inuline in management of functional diarrhoea in children – interventional study. Farmacia. 2019;67:511-516. [CrossRef]
  • 21. Schweiger J, Karlnoski R, Mangar D, et al. Impact of a low-pressure polyurethane adult endotracheal tube on the incidence of ventilator-associated pneumonia: A before and after concurrence study. ISRN Critical Care. 2013;13:1-6. [CrossRef]
Balkan Medical Journal-Cover
  • ISSN: 2146-3123
  • Başlangıç: 2015
  • Yayıncı: Erkan Mor
Sayıdaki Diğer Makaleler

Lobular Carcinoma In Situ Incidentally Detected by Dual-Energy Computed Tomography

Ahmet Gürkan ERDEMİR, Gamze DURHAN, Erhan AKPINAR

Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study

Harika Öykü DİNÇ, Mehmet DEMİRCİ, Yusuf Emre ÖZDEMİR, Serhat SİREKBASAN, Ayse Nur AKTAŞ, Yeşim Tuyji TOK, Doğukan ÖZBEY, Rüveyda AKÇİN, Nesrin GAREAYAGHİ, Mert Ahmet KUŞKUCU, Kenan MİDİLLİ, Gökhan AYGÜN, Suat SARIBAŞ, Bekir KOCAZEYBEK

Safety of an Inactivated SARS-CoV-2 Vaccine Among Healthcare Workers in Turkey: An Online Survey

Oya BAYDAR, Şennur ÖZEN, Burcu ÖZTÜRK ŞAHİN, Nurdan KÖKTÜRK, Mehmet Tevfik KİTAPÇI

The Significance of Tumor Budding and Immunohistochemical Axl Expression in Gallbladder Adenocarcinomas

Özden ÖZ, Asuman ARGON, Tulu KEBAT, Çisem NAMLI AKINCI, Özlem ÖZDEMİR

A Challenging Diagnosis: A Case of Multisystem Inflammatory Syndrome Following COVID-19 Vaccination

Reşit YILDIRIM, Mustafa DİNLER, Nazife Şule YAŞAR BİLGE, Timuçin KAŞİFOĞLU

Esophageal Injury Due to Long-term Use of Dabigatran

Akihiro MAEDA, Hirohisa FUJİKAWA, Tadamasa WAKABAYASHİ

Antibiotic use and Influencing Factors Among Hospitalized Patients with COVID-19: A Multicenter Point-Prevalence Study from Turkey

İrfan ŞENCAN, Yasemin ÇAĞ, Oğuz KARABAY, Behice KURTARAN, Ertuğrul GÜÇLÜ, Aziz ÖĞÜTLÜ, Zehra DEMİRBAŞ, Dilek BULUT, Gülden Eser KARLIDAĞ, Merve Sefa SAYAR, Ezgi Gizem ŞİBAR, Oya Özlem EREN KUTSOYLU, Gülnur KUL, Serpil EROL, Begüm BEKTAŞ, Tülay ÜNVER ULUSOY, Semanur KUZİ, Meltem TASBAKAN, Özge YİĞİT,

Identification and Validation of a Novel Nomogram Predicting 7-day Death in Patients with Intracerebral Hemorrhage

Mingming FAN, Qian HAN, Zhengyao ZUO, Dongpo SU, Qing WANG, Mei Lİ, Tong CHEN

MORC2 p.R252W Mutant Axonal Charcot–Marie–Tooth Disease Causes Peripheral Neuropathies and Pathological Myofiber Destruction

Yaye WANG, Jingzhe HAN, Jinru ZHANG, Yue WU, Xueqin SONG

Natural Evolution of Morquio A Syndrome Caused by Two Heterozygous Mutations of the GALNS Gene

Milos D PAJİC, Ivana I KAVECAN, Jadranka M MAKSİMOVİC, Sinisa S BABOVİC, Biljana T Bojadzieva STOJANOSKA